In patients with well-controlled diabetes, the risk of COVID-19 infection is no higher than in the general population1. However, if co-morbidities are present, the situation changes significantly2. What do you need to pay attention to?
These and other questions are answered by Prof. Roger Lehmann, MD., Stv. Clinic Director, Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich in the video.
The content of this video interview is for general information on the mentioned disease area and does not claim to be comprehensive or complete. The interview reflects the personal and independent opinion of Prof. Dr. med. Roger Lehmann and is intended for healthcare professionals working in Switzerland. All rights, namely copyrights to this video interview are exclusively owned by Mundipharma Medical Company, Basel Branch (“Mundipharma”). The video may not be modified, supplemented or redistributed without the express consent of Mundipharma.
1. Federal Office of Public Health. Coronavirus: strengthened protection of vulnerable individuals and evaluation of economic impact. https://www.bag.admin.ch/bag/de/home/das-bag/aktuell/medienmitteilungen.msg-id-78381.html. Last access: 01.04.2020
2nd Swiss Society of Endocrinology and Diabetology. Information regarding COVID-19 and the situation of adult patients with diabetes mellitus. https://www.sgedssed.ch/diabetologie/covid-19. Last access: 01.04.2020.
Also watch the webinar with Prof. Lehmann: “Practice Questions on the Current SGED Recommendations 2020” on Friday, June 19, 12:00-13:00.
You can find more information here.
